nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acquired KRAS mutations during progression of colorectal cancer metastases: possible implications for therapy and prognosis
|
Bouchahda, Mohamed |
|
2010 |
66 |
3 |
p. 605-609 |
artikel |
2 |
A phase I dose escalation and pharmacokinetic study of vatalanib (PTK787/ZK 222584) in combination with paclitaxel in patients with advanced solid tumors
|
Chiorean, E. Gabriela |
|
2009 |
66 |
3 |
p. 441-448 |
artikel |
3 |
A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancer
|
Nakachi, Kohei |
|
2009 |
66 |
3 |
p. 527-534 |
artikel |
4 |
Bendamustine: something old, something new
|
Tageja, Nishant |
|
2010 |
66 |
3 |
p. 413-423 |
artikel |
5 |
Differential apoptotic response of human cancer cells to organoselenium compounds
|
Suzuki, Maiko |
|
2009 |
66 |
3 |
p. 475-484 |
artikel |
6 |
DNA incorporation of 6-thioguanine nucleotides during maintenance therapy of childhood acute lymphoblastic leukaemia and non-Hodgkin lymphoma
|
Hedeland, Rikke L. |
|
2009 |
66 |
3 |
p. 485-491 |
artikel |
7 |
GCS induces multidrug resistance by regulating apoptosis-related genes in K562/AO2 cell line
|
Liu, Yan |
|
2009 |
66 |
3 |
p. 433-439 |
artikel |
8 |
Influence of DNA repair RAD51 gene variants in overall survival of non-small cell lung cancer patients treated with first line chemotherapy
|
Nogueira, Augusto |
|
2009 |
66 |
3 |
p. 501-506 |
artikel |
9 |
Ixabepilone plus capecitabine for Chinese patients with metastatic breast cancer progressing after anthracycline and taxane treatment
|
Wang, Jiayu |
|
2010 |
66 |
3 |
p. 597-603 |
artikel |
10 |
MDR1 C2005T polymorphism changes substrate specificity
|
Liu, Lijuan |
|
2010 |
66 |
3 |
p. 617-623 |
artikel |
11 |
Novel microtubule-targeting agents, pyrrolo-1,5-benzoxazepines, induce apoptosis in multi-drug-resistant cancer cells
|
Nathwani, Seema-Maria |
|
2009 |
66 |
3 |
p. 585-596 |
artikel |
12 |
Paclitaxel combined with ifosfamide in anthracycline- and docetaxel-pretreated metastatic breast cancer: activity independence of prior docetaxel resistance
|
Moon, Yong Wha |
|
2009 |
66 |
3 |
p. 425-431 |
artikel |
13 |
Patterns of relapse and metastatic spread in HER2-overexpressing breast cancer according to estrogen receptor status
|
Park, Yeon Hee |
|
2009 |
66 |
3 |
p. 507-516 |
artikel |
14 |
Phase II study of carboplatin combined with weekly docetaxel in patients with advanced non-small cell lung cancer
|
Jiang, Lian |
|
2009 |
66 |
3 |
p. 449-453 |
artikel |
15 |
Putative chemopreventive molecules can increase Nrf2-regulated cell defense in some human cancer cell lines, resulting in resistance to common cytotoxic therapies
|
Hu, Liangao |
|
2009 |
66 |
3 |
p. 467-474 |
artikel |
16 |
Synergistic interactions between aminoflavone, paclitaxel and camptothecin in human breast cancer cells
|
Reinicke, Kathryn E. |
|
2009 |
66 |
3 |
p. 575-583 |
artikel |
17 |
Targeted proteasome inhibition by Velcade induces apoptosis in human mesothelioma and breast cancer cell lines
|
Wang, Ying |
|
2009 |
66 |
3 |
p. 455-466 |
artikel |
18 |
The combination of ERCC1 and XRCC1 gene polymorphisms better predicts clinical outcome to oxaliplatin-based chemotherapy in metastatic colorectal cancer
|
Liang, Jun |
|
2009 |
66 |
3 |
p. 493-500 |
artikel |
19 |
The histone deacetylase inhibitor vorinostat induces calreticulin exposure in childhood brain tumour cells in vitro
|
Sonnemann, Jürgen |
|
2010 |
66 |
3 |
p. 611-616 |
artikel |